Pharmaceutical composition comprising a bispecific antibody for EpCAM

Details for Australian Patent Application No. 2004242847 (hide)

Owner Micromet AG

Inventors Wolf, Andreas; Bauerle, Patrick; Lenkkeri-Schutz, Ulla; Kufer, Peter; Offner, Sonja; Raum, Tobias; Berry, Meera; Kohleisen, Birgit; Brischwein, Klaus

Agent Griffith Hack

Pub. Number AU-B-2004242847

PCT Pub. Number WO2004/106383

Priority 03 01 2133.9 31.05.03 EP; 03 01 2134.7 31.05.03 EP

Filing date 26 May 2004

Wipo publication date 9 December 2004

Acceptance publication date 9 June 2011

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/106383 Priority application(s): WO2004/106383

9 June 2011 Application Accepted

  Published as AU-B-2004242847

6 October 2011 Standard Patent Sealed

20 September 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Amgen Research (Munich) GmbH . Address for service in Australia - Griffith Hack GPO Box 1285 Melbourne VIC 3001

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004242850-Substituted pyrazolopyrimidines, methods for the production thereof, use of the same for controlling pathogenic fungi, and agents containing said compounds

2004242846-Pharmaceutical compositions comprising bispecific anti-CD3, anti-CD19 antibody constructs for the treatment of Bcell related disorders